Amedica Corporation(NASDAQ:AMDA) reported the engagement of Dana Lyons as VP of Sales and Marketing. Lyons will lead the initiative to increase the acceptance of silicon nitride implants in the growing spinal fusion industry and offer revenue growth. He brings more than 27 years of sales management experience in the extensive medical device industry.
Mr. Lyons joined Amedica after serving on numerous sales leadership and sales management positions with Stryker Orthopaedics, Zimmer Biomet Spine and Zimmer Spine. During his tenure as Sales VP with Zimmer Spine and in association with the Zimmer Spine leadership team, the firm delivered 5 successive quarters of growth during FY2014 to FY2015. After the Biomet and Zimmer merger in June 2015, Lyons successfully combined the sales organizations of Biomet Spine and Zimmer Spine in the Central Region of the U.S.
Commenting on his new role, Lyons stated that he is thrilled to join Amedica at a turn-around stage, especially when the spine market is seeking a new material platform. They can drive the acceptance of silicon nitride in the buzzing spinal fusion industry, where it is an ideal solution for related clinical concerns. The exclusive material aspects of silicon nitride make an ideal selection for spinal fusion surgery.
The FDA notified the firm that the pedicle screw system named Taurus has been approved for commercialization. Amedica is on way for surgical implantation and a comprehensive market launch of this Taurus system by the close of the year. Lyons will implement a plan for expanded launch of new spine items, including the lateral lumbar fusion equipment and the Taurus pedicle screw mechanism. Approval of metals product portfolio is instantly relevant, and the new sales team will make efforts for proper positioning of this unique system, to drive revenue growth and leverage surgeon interest.
Amedica is establishing a top-tier sales team with experts from the spine industry. Going forward, the focus is on surgeon engagement, driving sales and data collection to prove the unmatched volume of basic material science information that the firm has already published.